| Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma SJ Schuster, MR Bishop, CS Tam, EK Waller, P Borchmann, JP McGuirk, ... New England Journal of Medicine 380 (1), 45-56, 2019 | 4407 | 2019 |
| A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning S Miraglia, W Godfrey, AH Yin, K Atkins, R Warnke, JT Holden, RA Bray, ... Blood, The Journal of the American Society of Hematology 90 (12), 5013-5021, 1997 | 1392 | 1997 |
| Peripheral-blood stem cells versus bone marrow from unrelated donors C Anasetti, BR Logan, SJ Lee, EK Waller, DJ Weisdorf, JR Wingard, ... New England Journal of Medicine 367 (16), 1487-1496, 2012 | 1124 | 2012 |
| Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study SJ Schuster, CS Tam, P Borchmann, N Worel, JP McGuirk, H Holte, ... The Lancet Oncology 22 (10), 1403-1415, 2021 | 619 | 2021 |
| Ibrutinib for chronic graft-versus-host disease after failure of prior therapy D Miklos, CS Cutler, M Arora, EK Waller, M Jagasia, I Pusic, ME Flowers, ... Blood, The Journal of the American Society of Hematology 130 (21), 2243-2250, 2017 | 592 | 2017 |
| Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results … P Armand, A Nagler, EA Weller, SM Devine, DE Avigan, YB Chen, ... Journal of clinical oncology 31 (33), 4199-4206, 2013 | 564 | 2013 |
| Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with … BL McClune, DJ Weisdorf, TL Pedersen, G Tunes da Silva, MS Tallman, ... Journal of Clinical Oncology 28 (11), 1878-1887, 2010 | 561 | 2010 |
| Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research S Arai, M Arora, T Wang, SR Spellman, W He, DR Couriel, ... Biology of blood and marrow transplantation 21 (2), 266-274, 2015 | 521 | 2015 |
| Human cytomegalovirus (CMV)-induced memory-like NKG2C+ NK cells are transplantable and expand in vivo in response to recipient CMV antigen B Foley, S Cooley, MR Verneris, J Curtsinger, X Luo, EK Waller, ... The Journal of Immunology 189 (10), 5082-5088, 2012 | 453 | 2012 |
| Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing M François, IB Copland, S Yuan, R Romieu-Mourez, EK Waller, ... Cytotherapy 14 (2), 147-152, 2012 | 425 | 2012 |
| Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies RJ Soiffer, J LeRademacher, V Ho, F Kan, A Artz, RE Champlin, S Devine, ... Blood, The Journal of the American Society of Hematology 117 (25), 6963-6970, 2011 | 422 | 2011 |
| Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma S Lonial, EK Waller, PG Richardson, S Jagannath, RZ Orlowski, CR Giver, ... Blood 106 (12), 3777-3784, 2005 | 406 | 2005 |
| Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population PG Richardson, AD Elias, A Krishnan, C Wheeler, R Nath, ... Blood, The Journal of the American Society of Hematology 92 (3), 737-744, 1998 | 327 | 1998 |
| Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT C Cutler, B Logan, R Nakamura, L Johnston, S Choi, D Porter, WJ Hogan, ... Blood, The Journal of the American Society of Hematology 124 (8), 1372-1377, 2014 | 271 | 2014 |
| Expression of factor VIII by murine liver sinusoidal endothelial cells H Do, JF Healey, EK Waller, P Lollar Journal of Biological Chemistry 274 (28), 19587-19592, 1999 | 268 | 1999 |
| Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: a Center for International Blood and Marrow Transplant … N Ghosh, R Karmali, V Rocha, KW Ahn, A DiGilio, PN Hari, V Bachanova, ... Journal of Clinical Oncology 34 (26), 3141-3149, 2016 | 257 | 2016 |
| Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD B Watkins, M Qayed, C McCracken, B Bratrude, K Betz, Y Suessmuth, ... Journal of clinical oncology 39 (17), 1865-1877, 2021 | 254 | 2021 |
| Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy DM Francis, MP Manspeaker, A Schudel, LF Sestito, MJ O’Melia, ... Science translational medicine 12 (563), eaay3575, 2020 | 251 | 2020 |
| Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice DA Dedera, EK Waller, DP LeBrun, A Sen-Majumdar, ME Stevens, ... Cell 74 (5), 833-843, 1993 | 242 | 1993 |
| Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at … V Gupta, MS Tallman, W He, BR Logan, E Copelan, RP Gale, HJ Khoury, ... Blood, The Journal of the American Society of Hematology 116 (11), 1839-1848, 2010 | 236 | 2010 |
